|
| N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine Basic information |
Product Name: | N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine | Synonyms: | 1,4-Benzenedimethanamine, N1,N4-di-2-pyridinyl-;N1,N4-di-2-pyridinyl-1,4-benzenedimethanamine WZ811;WZ 811 N,N'-Di-2-pyridinyl-1,4-benzenedimethanamine;WZ 811, >=98%;N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine;WZ 811;N,N'-(1,4-PHENYLENEBIS(METHYLENE))DIPYRIDIN-2-AMINE;N,N'-Di-2-pyridinyl-1,4-benzenedimethanamine | CAS: | 55778-02-4 | MF: | C18H18N4 | MW: | 290.36 | EINECS: | 200-256-5 | Product Categories: | Inhibitors | Mol File: | 55778-02-4.mol | |
| N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine Chemical Properties |
Melting point | 192-194℃ (methanol ) | Boiling point | 493.2±35.0 °C(Predicted) | density | 1.229±0.06 g/cm3(Predicted) | storage temp. | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C | solubility | DMSO: ≥7mg/mL | pka | 6.55±0.10(Predicted) | form | powder | color | white to tan |
Hazard Codes | Xn | Risk Statements | 22-36/37/38 | Safety Statements | 26 | WGK Germany | 3 | HS Code | 2933.39.6190 |
| N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine Usage And Synthesis |
Description | The CXC chemokine receptor-4 (CXCR4) is a G protein-coupled receptor that is specific for stromal cell-derived factor-1 (SDF-1/ CXCL12). Activation of CXCR4 promotes homing of hematopoietic stem cells, chemotaxis and quiescence of lymphocytes, and growth and metastasis of certain cancer cell types. Moreover, CXCR4 on CD4+ T-cells is used by CXCR4-selective HIV forms as a gateway for T-cell infection. WZ811 is a potent inhibitor of binding of an SDF-1 peptide mimic to CXCR4 (EC50 = 0.3 nM). It prevents SDF-1/CXCL12-mediated modulation of cAMP (EC50 = 1.2 nM) in cells and blocks SDF-1-induced Matrigel™ invasion by MDA-MB-231 human breast adenocarcinoma cells (EC50 = 5.2 nM). The effectiveness of WZ811 in animals remains to be elucidated. | Uses | N1,N4-di-2-Pyridinyl-1,4-benzenedimethanamine acts as an inhibitor for the chemokine receptor CXCR4. | references | [1] zhan w, liang z, zhu a, et al. discovery of small molecule cxcr4 antagonists. journal of medicinal chemistry, 2007, 50(23): 5655-5664. [2] choi w t, duggineni s, xu y, et al. drug discovery research targeting the cxc chemokine receptor 4 (cxcr4). journal of medicinal chemistry, 2011, 55(3): 977-994. |
| N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine Preparation Products And Raw materials |
|